Change in the localization of heat shock protein 27 (HSP 27) in BG-1 human ovarian cancer cells following treatment by the ether lipid ET-18-OCH3

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 181-187

  Fujiwara, Keiichi ^a   Shirafuji, Hiroko ^a   Fushitani, Kenzo ^a   Fujimoto, Katsukuni ^a   Kohno, Ichiro ^a   Modest, Edward J ^b  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ether lipid; HSP27; Hypodiploid fraction; Ovarian cancer cell; Translocation

Indexed keywords

ETHER LIPID; HEAT SHOCK PROTEIN 27; NUCLEAR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; OVARY CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; AMINO ACID SEQUENCE; CELL NUCLEUS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PHOSPHATIDYLCHOLINES; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0032945845     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Noseda A, White JG, Godwin PL, Jerome WG, and Modest EJ: Membrane damage in leukemic cells induced by ether and ester lipids: an electron microscopic study. Exp Mol Pathol 50: 69-83, 1989.
2. Lohmeyer M and Bittman R: Antitumor ether lipids and alkylphosphocholines. Drugs of the Future 19: 10021-1027, 1994.
3. Berdel WE, Becher B, Eibl H, and et al: Daily oral miltefosine (hexadecylphophocholine) in patients with advanced non-small cell lung cancer. A phase II study. Onkologie 15: 238-242, 1992.
4. Unger C, Sindermann H, Peukert M, Hilgard P, Engel J, and Eibl H: Hexadecylphosphocholine in the topical treatment of skin metasitases in breast cancer patients. Prog Exp Tumor Res 34: 1591992.
5. Dummer R, Krasovec M, Roger J, Sindermann H, and Burg G: Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: Results of a phase I/II study. J Amer Acad Dermatol 29: 9701993.
6. Koenigsmann MP, Notter M, Knauf WU, Papadimitriou CA, Oberberg D, Reufi B, Mucke C, Thiel E, and Berdel WE: Chemopurging of peripheral blood-derived progenitor cells by alkyllysophospholipid and its effect on haematopoietic rescue after high-dose therapy. Bone Marrow Transplant 18: 549-557, 1996.
7. Ahmad I, Filep JJ, Franklin JC, Janoff AS, Masters GR, Pattassery J, Peters A, Schupsky JJ, Zha Y, and Mayhew E: Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine. Cancer Res 57: 1915-1921, 1997.
8. Hilgard P, Klenner T, Stekar J, Nossner G, Kutscher B, and Engel J: D-21266, a new heterocyclic alkylphospholipid with antitumour activity. Eur J Cancer 33: 442-446, 1997.
9. Fujiwara K, Koike H, Ohishi Y, Shirafuji H, Kohno I, Modest EJ, and Kataoka S: Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide. Anticancer Res 17: 2159-2167, 1997.
10. Geisinger KR, Kute TE, Pettenati MJ, Welander CE, Dennard Y, Collins LA, and Berens ME: Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors. Cancer 63: 280-288, 1989.
11. Fujiwara K, Modest EJ, Welander CE, and Wallen CA: Cytotoxic interactions of heat and an ether lipid analogue in human ovarian carcinoma cells. Cancer Res 49: 6285-6289, 1989.
12. Hickey E, Brandon SE, Potter R, Stein G, Stein J, and Weber LA: Sequence and organization of genes encoding the human 27 kDa heat shock protein [published erratum appears in Nucleic Acids Res 1986 Oct 24; 14(20): 8230]. Nucleic Acids Res 14: 4127-4145, 1986.
13. Lavoie J, Chretien P, and Landry J: Sequence of the Chinese hamster small heat shock protein HSP27. Nucleic Acids Res 18: 16371990.
14. Carper SW, Rocheleau TA, and Storm FK: cDNA sequence of a human heat shock protein HSP27. Nucleic Acids Res 18: 64571990.
15. Huot J, Roy G, Lambert H, Chretien P, and Landry J: Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein. Cancer Res 51: 5245-5252, 1991.
16. Richards EH, Hickey E, Weber L, and Master JR: Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells. Cancer Res 56: 2446-2451, 1996.
17. Uozaki H, Horiuchi H, Ishida T, Iijima T, Imamura T, and Machinami R: Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis. Cancer 79: 2336-2344, 1997.
18. Garrido C, Mehlen P, Fromentin A, Hammann A, Assem M, Arrigo AP, and Chauffert B: Inconstant association between 27-kDa heat-shock protein (Hsp27) content and doxorubicin resistance in human colon cancer cells. The doxorubicin-protecting effect of Hsp27. Eur J Biochem 237: 653-659, 1996.
19. Hettinga JV, Lemstra W, Meijer C, Los G, de VE, Konings AW, and Kampinga HH: Heat-shock protein expression in cisplatin-sensitive and -resistant human tumor cells. Int J Cancer 67: 800-807, 1996.
20. Vargas RL, Fanelli MA, Lopez LA, Gago FE, Tello O, Aznar JC, and Ciocca DR: Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prev 21: 441-451, 1997.
21. Germain I, Tetu B, Brisson J, Mondor M, and Cherian MG: Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases. Int J Gynecol Pathol 15: 54-62, 1996.
22. Geisler JP, Geisler HE, Tammela J, Wiemann MC, Zhou Z, Miller GA, and Grabtree W: A study of heat shock protein 27 in endometrial carcinoma. Proc Ameriacan Association for Cancer Res 39: 149-149, 1998. (Abstract)
23. Geisler JP, Geisler HE, Tammela J, Wiemann MC, Zhou Z, Miller GA, and Crabtree W: Heat Schok Protein 27: An independent prognostic Indicator of survival in patients with epithelial ovarian carcinoma. Gynecol Oncol In Press: 1998.
24. Huot J, Lambert H, Lavoie JN, Guimond A, Houle F, and Landry J: Characterization of 45-kDa/54-kDa HSP27 kinase, a stress-sensitive kinase which may activate the phosphorylation-dependent protective function of mammalian 27-kDa heat-shock protein HSP27. Eur J Biochem 227: 416-427, 1995.
25. Lavoie JN, Hickey E, Weber LA, and Landry J: Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J Biol Chem 268: 24210-24214, 1993.
26. Huot J, Houle F, Spitz DR, and Landry J: HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res 56: 273-279, 1996.
27. Ahlers A, Belka C, Gaestel M, Lamping N, Sott C, Herrmann F, and Brach MA: Interleukin-1-induced intracellular signaling pathways converge in the activation of mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 and the subsequent phosphorylation of the 27-kilodalton heat shock protein in monocytic cells. Mol Pharmacol 46: 1077-1083, 1994.
28. Ahlers A, Engel K, Sott C, Gaestel M, Herrmann F, and Brach MA: Interleukin-3 and granulocyte-macrophage colony-stimulating factor induce activation of the MAPKAP kinase 2 resulting in in vitro serine phosphorylation of the small heat shock protein (Hsp 27). Blood 83: 1791-1798, 1994.
29. Belka C, Ahlers A, Sott C, Gaestel M, Herrmann F, and Brach MA: Interleukin (IL)-6 signaling leads to phosphorylation of the small heat shock protein (Hsp)27 through activation of the MAP kinase and MAPKAP kinase 2 pathway in monocytes and monocytic leukemia cells. Leukemia 9: 288-294, 1995.
30. Engel K, Ahlers A, Brach MA, Herrmann F, and Gaestel M: MAPKAP kinase 2 is activated by heat shock and TNF-alpha: in vivo phosphorylation of small heat shock protein results from stimulation of the MAP kinase cascade. J Cell Biochem 57: 321-330, 1995.
31. Rouse J, Cohen P, Trigon S, Morange M, Alonso LA, Zamanillo D, Hunt T, and Nebreda AR: A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78: 1027-1037, 1994.
32. Lavoie JN, Lambert H, Hickey E, Weber LA, and Landry J: Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol Cell Biol 15: 505-516, 1995.
33. Daniel LW, Etkin LA, Morrison BT, Parker J, Morris NS, Surles JR, and Piantadosi C: Ether lipids inhibit the effects of phorbol diester tumor promoters. Lipids 22: 851-855, 1987.
34. Zhou X and Arthur G: 1-O-Octadecyl-2-O-methylglycerophosphocholine inhibits protein kinase C-dependent phosphorylation of endogenous proteins in MCF-7 cells. Biochem J, 324: 897-902, 1997.
35. Powis G: Drugs active against growth factor and oncogene phosphatidylinositol signalling pathways. Semin Cancer Biol 3: 343-350, 1992.
36. Zhou X, Lu X, Richard C, Xiong W, Litchfield DW, Bittman R, and Arthur G: 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells. J Clin Invest 98: 937-944, 1996.
37. Arrigo AP and Pauli D: Characterization of HSP27 and three immunologically related polypeptides during Drosophila development. Exp Cell Res 175: 169-183, 1988.
38. Arrigo AP: The monovalent ionophore monensin maintains the nuclear localization of the human stress protein hsp28 during heat shock recovery. J Cell Sci 96: 419-427, 1990.
39. Mehlen P, Briolay J, Smith L, Diaz IC, Fabre N, Pauli D, and Arrigo AP: Analysis of the resistance to heat and hydrogen peroxide stresses in COS cells transiently expressing wild type or deletion mutants of the Drosophila 27-kDa heat-shock protein. Eur J Biochem 215: 277-284, 1993.
40. Vargas RL, Gago FE, Tello O, Aznar JC, and Ciocca DR: Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer In Press: 1998.
41. Nozaki J, Takehana M, and Kobayashi S: UVB irradiation induces changes in cellular localization and phosphorylation of mouse HSP27. Photochem Photobiol 65: 843-848, 1997.
42. Garrido C, Ottavi P, Fromentin A, Hammann A, Arrigo AP, Chauffert B, and Mehlen P: HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res 57: 2661-2667, 1997.
43. Biggiogera M, Tanguay RM, Marin R, Wu Y, Martin TE, and Fakan S: Localization of heat shock proteins in mouse male germ cells: an immunoelectron microscopical study. Exp Cell Res 229: 77-85, 1996.
44. Arrigo AP and Landry J: Expression and Function of the Low-molecular-weight Heat Shock Proteins. In: R.I. Morimoto A. Tissieres and C. Georgopoulos (eds.), The Biology of Heat Shock Proteins and Molecular Chaperones, pp. 335-373, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. 1994.